NEW YORK, June 27, 2017 /PRNewswire/ --
If you want a Stock Review on CVS, ESRX, AET or CI then come over to http://dailystocktracker.com/register/and sign up for your free customized report today. Featured on DailyStockTracker.com today are these four stocks: CVS Health Corp. (NYSE: CVS), Express Scripts Holding Co. (NASDAQ: ESRX), Aetna Inc. (NYSE: AET), and Cigna Corp. (NYSE: CI). Health Care
Shares in Woonsocket, Rhode Island headquartered CVS Health Corp. rose 3.50%, ending Monday's trading session at $80.12. The stock recorded a trading volume of 8.65 million shares, which was higher than its three months average volume of 6.44 million shares. The Company's shares have gained 5.49% in the last one month, 2.05% over the last three months, and 1.53% on an YTD basis. The stock is trading 1.39% above its 50-day moving average. Moreover, shares of CVS Health, which together with its subsidiaries, provide integrated pharmacy health care services, have a Relative Strength Index (RSI) of 55.44.
On June 21st, 2017, CVS Health was recognized by Points of Light, the world's largest organization dedicated to volunteer service, as one of the fifty most community-minded companies in the US. The Civic 50 provides a national standard for superior corporate citizenship, and showcases how companies can use their time, skills, and other resources to improve the quality of life in the communities where they do business. Visit us today and access your complete report on CVS for free at:
Saint Louis, Missouri headquartered Express Scripts Holding Co.'s stock climbed 0.46%, closing the day at $65.52 with a total trading volume of 2.74 million shares. The Company's shares have advanced 9.04% in the past month and 1.42% in the previous three months. The stock is trading 5.55% above its 50-day moving average. Additionally, shares of Express Scripts, which operates as a pharmacy benefit management company in the US, Canada, and Europe, have an RSI of 73.15.
On June 07th, 2017, Express Scripts Holding announced a new, Advanced Opioid Management[SM] solution that will better address the US' opioid-addiction epidemic by working comprehensively with patients, prescribers, and pharmacies to minimize early exposure, while helping prevent progression to overuse and abuse. Building on the success of the pilot, the Company added novel opioid management features, addressing other points on the care continuum, from safe disposal, to tools for physicians at the point of care and safety checks for dispensing pharmacies. The complimentary research report on ESRX can be accessed at:
On Monday, shares in Hartford, Connecticut-based Aetna Inc. recorded a trading volume of 1.49 million shares. The stock ended the day 0.60% lower at $151.19. The Company's shares have advanced 4.10% in the past month, 19.74% in the previous three months, and 21.92% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 6.20% and 18.88%, respectively. Furthermore, shares of Aetna, which operates as a health care benefits company in the US, have an RSI of 65.99.
On June 09th, 2017, research firm RBC Capital Markets reiterated its 'Outperform' rating on the Company's stock with an increase of the target price from $147 a share to $162 a share.
On June 21st, 2017, Aetna announced a new, collaborative agreement with Community Care Physician Network, LLC (CCPN), to develop innovative ways to transform how health care is delivered in North Carolina. Beginning in January 2018, Aetna will combine its expertise in alternative value-based delivery models with CCPN independent physicians' advanced medical homes, in association with the care management expertise of Community Care of North Carolina, Inc. Register for free on DailyStockTracker.com and download the research report on AET at:
Bloomfield, Connecticut headquartered Cigna Corp.'s stock dropped 0.80%, finishing yesterday's session at $168.26 with a total trading volume of 1.41 million shares. The Company's shares have advanced 4.09% in the last one month, 15.22% in the previous three months, and 26.14% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 4.16% and 16.53%, respectively. Additionally, shares of Cigna, which provides insurance and related products and services in the US and internationally, have an RSI of 59.98.
On June 22nd, 2017, Cigna announced that, in demonstrating its commitment to NHL's Every Save Counts™ campaign, the Cigna Foundation donated $100,000 to the National Hockey League Foundation in support of Hockey Fights Cancer™, which is part of NHL's ongoing effort to support and raise awareness for national and local organizations involved in cancer care and research. Get free access to your research report on CI at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: firstname.lastname@example.org Phone number: (207) 331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All